Since 1989, the Lynn Health Science Institute (LHSI) has been conducting comprehensive medical research. Bringing new drugs to market through its clinical trials program, LHSI has extensive experience in a number of areas, including chronic digestive diseases; cardiovascular diseases and hypertension; disorders such as asthma, lung infections, and cystic fibrosis; women’s health; urology; rheumatoid and osteoarthritis; and sleep disorders.
By Matt Gurin
Congratulations! You’ve been promoted. You’re a global leader in the new R&D organization. This is exciting since you’ve been sweating the outcome of the long-impending transformation for over a year. The good news is that you will lead a global team spanning three continents. The bad news is that your drug development function will be spread across four global centers of excellence, and some of your colleagues will lose their jobs or be transferred.
Eurofins MWG Operon has opened a new DNA sequencing facility in the San Francisco area.
Study shows companies conducting R&D in Melbourne bear 88 percent less tax burden than in U.S.
Aragen Bioscience, Inc., today announced it is a subcontractor on a National Institute of Allergy and Infectious Diseases (NIAID) contract for the preclinical development of monoclonal antibodies for the prevention and treatment of infectious diseases.
Pfēnex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement for the use of Pfēnex Expression Technology™
Advanced Clinical, a leading provider of clinical research services, announced that Executive Vice President Rosemarie Truman will speak on “How to Pick the Right Products/Solutions to Drive Profitable Growth” in biotechnology at the BioFlorida Event in Miami on Thursday, January 27, 2011.
Funding will be provided by SAIC through its Malaria Vaccine Production and Support Services Contract with the National Institute of Allergy and Infectious Diseases' (NIAID) Division of Microbiology and Infectious Diseases (DMID), part of the National Institutes of Health
Want more? Visit...